Thompson Siegel & Walmsley LLC Viatris Inc Transaction History
Thompson Siegel & Walmsley LLC
- $6.71 Billion
- Q3 2024
A detailed history of Thompson Siegel & Walmsley LLC transactions in Viatris Inc stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 5,930,904 shares of VTRS stock, worth $74.8 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
5,930,904
Previous 6,037,189
1.76%
Holding current value
$74.8 Million
Previous $64.2 Million
7.3%
% of portfolio
1.03%
Previous 1.03%
Shares
16 transactions
Others Institutions Holding VTRS
# of Institutions
1,099Shares Held
930MCall Options Held
2.68MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA141MShares$1.78 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.17 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$797 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$791 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$616 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.3B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...